Page last updated: 2024-08-24

epigallocatechin gallate and tg 003

epigallocatechin gallate has been researched along with tg 003 in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Bui, LC; Cariou, K; Dairou, J; Delabar, JM; Denhez, C; Dodd, RH; Gourdain, S; Janel, N; Rodrigues-Lima, F1
Bharate, SB; Joshi, P; Kumar, A; Sharma, S; Vishwakarma, RA; Wani, A; Yadav, RR1
Jarhad, DB; Jeong, LS; Kim, HR; Mashelkar, KK; Noh, M1
Bian, J; Huang, J; Jiang, W; Li, Z; Tang, J; Xie, Y; Zhang, L1

Reviews

2 review(s) available for epigallocatechin gallate and tg 003

ArticleYear
Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A (DYRK1A) Inhibitors as Potential Therapeutics.
    Journal of medicinal chemistry, 2018, 11-21, Volume: 61, Issue:22

    Topics: Animals; Biological Products; Disease; Dyrk Kinases; Enzyme Activation; Humans; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases

2018
A critical update on the strategies towards small molecule inhibitors targeting Serine/arginine-rich (SR) proteins and Serine/arginine-rich proteins related kinases in alternative splicing.
    Bioorganic & medicinal chemistry, 2022, 09-15, Volume: 70

    Topics: Alternative Splicing; Arginine; Humans; Nuclear Proteins; Phosphorylation; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Serine; Serine-Arginine Splicing Factors

2022

Other Studies

2 other study(ies) available for epigallocatechin gallate and tg 003

ArticleYear
Development of DANDYs, new 3,5-diaryl-7-azaindoles demonstrating potent DYRK1A kinase inhibitory activity.
    Journal of medicinal chemistry, 2013, Dec-12, Volume: 56, Issue:23

    Topics: Dyrk Kinases; Enzyme Inhibitors; Humans; Hydrogen Bonding; Indoles; KB Cells; Molecular Docking Simulation; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Pyridines

2013
Meridianin derivatives as potent Dyrk1A inhibitors and neuroprotective agents.
    Bioorganic & medicinal chemistry letters, 2015, Aug-01, Volume: 25, Issue:15

    Topics: Cell Line, Tumor; Dyrk Kinases; Humans; Indole Alkaloids; Indoles; Models, Molecular; Neurons; Neuroprotective Agents; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Pyrimidines; Structure-Activity Relationship

2015